Article Information
History
- February 27, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Matthew F. Wipperman1,2,#,
- Shakti K. Bhattarai3,#,
- Charles Kyriakos Vorkas1,4,
- Ying Taur5,
- Laurent Mathurin6,
- Katherine McAulay7,
- Stalz Charles Vilbrun6,
- Daphie Jean Francois11,
- James Bean1,
- Kathleen F. Walsh7,
- Carl Nathan8,
- Daniel W. Fitzgerald7,
- Michael S. Glickman1,4,8,* and
- Vanni Bucci3,9,10,*
- 1Immunology Program, Sloan Kettering Institute
- 2Clinical and Translational Science Center, Weill Cornell Medicine
- 3Department of Microbiology and Physiological Systems, University of Massachusetts Medical School
- 4Division of Infectious Diseases, Weill Cornell Medicine
- 5Division of Infectious Diseases, Memorial Sloan Kettering Cancer Center
- 6Haitian Study Group for Kaposi’s Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti
- 7Center for Global Health, Weill Cornell Medicine
- 8Immunology and Microbial Pathogenesis Graduate Program, Weill Cornell Graduate School
- 9Center for Microbiome Research, University of Massachusetts Medical School
- 10Program in Systems Biology, University of Massachusetts Medical School
- 11Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, USA
- ↵*Correspondence to: Vanni Bucci, PhD, Microbiology and Physiological Systems, Program in Systems Biology, Center for Microbiome Research, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA 01605, 774-856-2215, vanni.bucci2{at}umassmed.edu, Michael S. Glickman MD, Immunology Program, Sloan Kettering Institute, 1275 York Ave, New York, NY 10065, 6468882368, glickmam{at}mskcc.org
↵# these authors contributed equally